Drug-resistant tuberculosis : an experience from Qatar
This study was conducted to evaluate the characteristics, treatment outcome and risk factors associated with 223 drug-resistant tuberculosis (DR-TB) cases in the State of Qatar. A descriptive records-based retrospective study was conducted on patients registered at Communicable Disease Centre (CDC), Qatar to all consecutive microbiologically confirmed tuberculosis cases for the period January 2010 - March 2015. Demographic, clinical data, drug-resistance pattern of isolated mycobacteria and treatment outcome was assessed for the patient who completed their treatment in Qatar. Of 3301 patients with positive M. tuberculosis culture were analyzed; 223 (6.7%) were resistant to at least one drug. The overall prevalence of multi-d rug resistant TB (MDR-TB) was 1.2% (n = 38) of patients. A former resident of Indian sub contents was the most common demographic characteristic observed (64.1%). The outcome of treatment was assessed for 85 resistant cases with follow-up after completion of treatment. Cure and relapse rates were 97.6%, and 2.4%, respectively. Drug-resistant TB in Qatar is influenced by migration where the patients were probably infected. Rapid sputum sampling performed in the early stages of the disease, patient isolation, and drug-susceptibility testing should be the standard of care.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
The Libyan journal of medicine - 15(2020), 1 vom: 15. Dez., Seite 1744351 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ali, Maisa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antitubercular Agents |
|---|
| Anmerkungen: |
Date Completed 13.10.2020 Date Revised 13.11.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1080/19932820.2020.1744351 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM308236254 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM308236254 | ||
| 003 | DE-627 | ||
| 005 | 20231225131315.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/19932820.2020.1744351 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1027.xml |
| 035 | |a (DE-627)NLM308236254 | ||
| 035 | |a (NLM)32238120 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ali, Maisa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Drug-resistant tuberculosis |b an experience from Qatar |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.10.2020 | ||
| 500 | |a Date Revised 13.11.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a This study was conducted to evaluate the characteristics, treatment outcome and risk factors associated with 223 drug-resistant tuberculosis (DR-TB) cases in the State of Qatar. A descriptive records-based retrospective study was conducted on patients registered at Communicable Disease Centre (CDC), Qatar to all consecutive microbiologically confirmed tuberculosis cases for the period January 2010 - March 2015. Demographic, clinical data, drug-resistance pattern of isolated mycobacteria and treatment outcome was assessed for the patient who completed their treatment in Qatar. Of 3301 patients with positive M. tuberculosis culture were analyzed; 223 (6.7%) were resistant to at least one drug. The overall prevalence of multi-d rug resistant TB (MDR-TB) was 1.2% (n = 38) of patients. A former resident of Indian sub contents was the most common demographic characteristic observed (64.1%). The outcome of treatment was assessed for 85 resistant cases with follow-up after completion of treatment. Cure and relapse rates were 97.6%, and 2.4%, respectively. Drug-resistant TB in Qatar is influenced by migration where the patients were probably infected. Rapid sputum sampling performed in the early stages of the disease, patient isolation, and drug-susceptibility testing should be the standard of care | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Extra-Pulmonary TB | |
| 650 | 4 | |a MDR-TB | |
| 650 | 4 | |a Pulmonary TB | |
| 650 | 4 | |a Rifampicin | |
| 650 | 4 | |a XDR-TB | |
| 650 | 7 | |a Antitubercular Agents |2 NLM | |
| 700 | 1 | |a Howady, Faraj |e verfasserin |4 aut | |
| 700 | 1 | |a Munir, Waqar |e verfasserin |4 aut | |
| 700 | 1 | |a Karim, Hanfa |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Suwaidi, Zubaida |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Maslamani, Muna |e verfasserin |4 aut | |
| 700 | 1 | |a Alkhal, Abdullatif |e verfasserin |4 aut | |
| 700 | 1 | |a Elmaki, Nada |e verfasserin |4 aut | |
| 700 | 1 | |a Ziglam, Hisham |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Libyan journal of medicine |d 2006 |g 15(2020), 1 vom: 15. Dez., Seite 1744351 |w (DE-627)NLM207383537 |x 1819-6357 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2020 |g number:1 |g day:15 |g month:12 |g pages:1744351 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/19932820.2020.1744351 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2020 |e 1 |b 15 |c 12 |h 1744351 | ||